Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.

Jamshidi, Y; Flavell, D M; Hawe, E; MacCallum, P K; Meade, T W; Humphries, S E

Jamshidi, Y; Flavell, D M; Hawe, E; MacCallum, P K; Meade, T W; Humphries, S E.

Affiliation

Jamshidi Y; Centre for Cardiovascular Genetics, Department of Medicine, Royal Free and University College London Medical School, The Rayne Institute, London, UK.

Atherosclerosis ; 163(1): 183-92, 2002 Jul.

Article de En | MEDLINE | ID: mdl-12048138

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Polymorphisme génétique / Artériopathies oblitérantes / Bézafibrate / Maladies vasculaires périphériques / Hypolipémiants Type d'étude: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Atherosclerosis Année: 2002 Type de document: Article Pays d'affiliation: Royaume-Uni

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links